MAPRx is helping patients navigate open enrollment
It is open enrollment season for Medicare Part D, and the patient-led advocacy ...
Read More
BIO explains drug development process in California Supreme Court brief supporting Gilead
Drugmakers dealing with the complex process of developing medicines must be allowed to ...
Read More
BIO makes recommendation for new FDA Rare Disease Innovation Hub
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare ...
Read More
CMS must address Part D plan abuse of IRA provisions designed to protect patient access
The Biotechnology Innovation Organization (BIO) has once again requested that the Centers for ...
Read More
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, ...
Read More
CPAC supports FTC action against pharmacy benefit managers
Despite frequent criticism of the Federal Trade Commission (FTC), the Conservative Political Action ...
Read More
EDITORS' CHOICE
PHAS 2024: Patient advocates unite to share stories and address barriers to treatment
Patient advocates from across the country gathered in Washington, D.C., on October 23-24 for the BIO Patient and Health Advocacy Summit (PHAS). This event served ...
October 28, 2024
Read More
LATEST NEWS
Health
MAPRx is helping patients navigate open enrollment
It is open enrollment season for Medicare Part D, and the patient-led advocacy coalition MAPRx is helping patients get the coverage they need. Open enrollment ...
November 11, 2024
Health
BIO explains drug development process in California Supreme Court brief supporting Gilead
Drugmakers dealing with the complex process of developing medicines must be allowed to decide against trying to bring a drug to market, the Biotechnology Innovation ...
November 8, 2024
BIO's View
BIO makes recommendation for new FDA Rare Disease Innovation Hub
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare Disease Innovation Hub in July 2024. With the goal of engaging patients ...
November 8, 2024
BIO's View
CMS must address Part D plan abuse of IRA provisions designed to protect patient access
The Biotechnology Innovation Organization (BIO) has once again requested that the Centers for Medicare & Medicaid Services (CMS) take steps to protect patient access, asking ...
November 4, 2024
BIO Events
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience Training Center; Megan Heaphy, Director, ...
November 4, 2024
HEALTH
MAPRx is helping patients navigate open enrollment
November 11, 2024
BIO makes recommendation for new FDA Rare Disease Innovation Hub
November 8, 2024
CPAC supports FTC action against pharmacy benefit managers
October 31, 2024
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
NYT highlights how Pivot Bio is helping farmers and the environment
October 25, 2024
What to know about BIO’s 7 Core Strategic Priorities
October 3, 2024
Senate Sustainable Aviation Caucus to back pro-SAF legislation
September 30, 2024
Climate Change
What to know about BIO’s 7 Core Strategic Priorities
October 3, 2024
With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve ...
Read More
Senate Sustainable Aviation Caucus to back pro-SAF legislation
September 30, 2024
What to know about Valley fever vaccine development
September 9, 2024
USDA approves genetic trait that helps wheat handle drought
August 30, 2024
Federal Policy
State Policy
Rep. Hank Johnson and BIO tour biotech training facility in Atlanta
November 4, 2024
Pictured, from left: Scott McMurray, Deputy Commissioner, Georgia Quick Start; Dave Penake, CEO, Saol Therapeutics; Margie Battle, Manager, Georgia BioScience ...
Read More
International
AMR continues to pose a global threat
October 10, 2024
BIO speaks on Capitol Hill about mpox preparedness
October 3, 2024
Bio's View
BIO makes recommendation for new FDA Rare Disease Innovation Hub
November 8, 2024
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare Disease Innovation Hub in July 2024. With ...
Read More